Evidence map›Paper›PMID 30895184›Full record

ReviewERJ open research2019

Research highlights from the 2018 European Respiratory Society International Congress: airway disease.

Florence Schleich, Andras Bikov, Alexander G Mathioudakis, Melissa McDonnell, Cecilia Andersson, Matteo Bonini, Lena Uller, Marco Idzko, Dave Singh, Jose Luis Lopez-Campos and 5 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in ERJ open research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Epigenetic Mechanisms in Allergy Development and Prevention.Handbook of experimental pharmacology · 2022
    Article
  3. Current developments and future directions in COPD.European respiratory review : an official journal of the European Respiratory Society · 2020
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Florence SchleichDept of Pulmonary Medicine, CHU Sart-Tilman and I3 GIGA Research Group, University of Liège, Liège, Belgium.
Andras BikovDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester, UK.
Alexander G MathioudakisDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester, UK.
Melissa McDonnellDept of Respiratory Medicine, Galway University Hospitals, Galway, Ireland.
Cecilia AnderssonUnit of Respiratory Cell Biology, Dept of Experimental Medical Science, Lund University, Lund, Sweden.
Matteo BoniniUOC Pneumologia, Istituto di Medicina Interna, F. Policlinico Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Lena UllerUnit of Respiratory Immunopharmacology, Dept of Experimental Medical Science, Lund University, Lund, Sweden.
Marco IdzkoDept of Pneumology, Medical University of Vienna, Vienna, Austria.
Dave SinghMedicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK.
Jose Luis Lopez-CamposUnidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla, Seville, Spain.
Apostolos BossiosDept of Respiratory Medicine and Allergy, Karolinska University Hospital, Huddinge, Sweden.
Ian M AdcockNational Heart and Lung Institute, Imperial College London, London, UK.
Omar UsmaniNational Heart and Lung Institute, Imperial College London, London, UK.
Antonio SpanevelloIstituti Clinici Scientifici Maugeri, Università degli Studi Insubria, Tradate, Italy.
Sara J BonviniNational Heart and Lung Institute, Imperial College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The annual European Respiratory Society (ERS) International Congress (held in Paris in 2018) was once again a platform for discussion of the highest-quality scientific research, cutting-edge techniques and innovative new therapies within the respiratory field. This article discusses only some of the high-quality research studies presented at this year's Congress, with a particular focus on airway diseases including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis and cough, as presented through Assembly 5 of the ERS (Airway Diseases: Asthma and COPD). The authors establish the key take-home messages of these studies, compare their findings and place them in the context of current understanding.

Identifiers

PMID30895184
PMCPMC6421359

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.